Checking Out Check Point

Recs

0

Internet security expert Check Point Software Technologies (Nasdaq: CHKP) issued a review of its 2005 results on Monday. Should we be interested in this stock? Let's see what the numbers tell us.

For the fourth quarter, total revenues increased 9% to $156.1 million. Operating income improved by 17%, totaling $93.3 million. Net income was $89.2 million ($0.36 per diluted share) compared to $76.4 million ($0.30 per diluted share) in the year-ago period. That's 17% earnings growth year over year.

For all of 2005, revenues jumped 12% to $579.4 million. Operating income grew by 27%, coming in at $331.7 million. Net income was $319.7 million ($1.27 per diluted share) versus $248.4 million ($0.95 per diluted share) for 2004, an appreciation of 29%.

It looks like Check Point had a nice year. The financial tale is positive on the cash-flow side as well. For the quarter, net cash from operating activities increased 11% to $81.5 million; free cash flow also jumped 11% to $80.1 million. For the full year, net cash from operating activities increased 22% to $346.9 million; free cash flow again expanded by the same percentage, coming in at $342.1 million.

Looking at some key stats, we can see that Check Point does well on profit margins, return on assets, and return on equity. It has no long-term debt and a reasonable enterprise value-to-free cash flow ratio of 12. All in all, I'm impressed.

Yet the stock hasn't exactly rocketed after the fourth-quarter news. For one thing, guidance wasn't what the market wanted to hear. In addition, investors seeking growth might balk at paying up for a company whose near-term growth rate isn't necessarily spectacular -- Check Point isn't expected to fare much better than the overall market. Given its high P/E-to-growth ratio, that isn't necessarily enticing. A look at the long-term chart also shows Check Point's rocky past, which doesn't necessarily portend a benign future.

I like the Internet security sector, and I believe it will be an important industry going forward. But there's a lot of competition here, including RSA Security (Nasdaq: RSAS), Secure Computing (Nasdaq: SCUR), and Symantec (Nasdaq: SYMC). I just don't see the market rewarding Check Point's shares with rampant appreciation anytime soon. I personally wouldn't be a buyer without a pullback that made the stock an unambiguous value. Nonetheless, I think CheckPoint requires further investigation.

Check out some related Takes:

Check into the Check Point Software Technologies discussion board.

Fool contributor Steven Mallas owns none of the companies mentioned. The Fool has a disclosure policy.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 511045, ~/Articles/ArticleHandler.aspx, 11/10/2009 8:00:05 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Health-Care Reform: A Tale of Two Chambers

Related Tickers

11/9/2009 4:00 PM
CHKP $32.61 Up +0.30 +0.93%
Check Point Softwa… CAPS Rating: ***
SCUR $5.75 Down +0.00 +0.00%
Secure Computing C… CAPS Rating: *****
SYMC $17.71 Up +0.29 +1.66%
Symantec Corp CAPS Rating: **

Community: Investing Wiki

Term Of The Hour

Biotechnology: Biotechnology uses biological processes to solve problems in such areas as health and medicine, agriculture and manufacturing.

Want to learn more or edit this definition?
Click here to read more!